What Analysts Have to Say About the Nokia Deal
Nokia made waves in the market following news of the extension of a licensing agreement. Merrill Lynch believes that this new agreement will have an impact on revenues for 2016.
All Work
Chris Lange
How the House of Morgan Won Earnings
Considering the recent uncertainty and turbulence in the markets from the Brexit, JPMorgan impressed yet again with its most recent earnings report. Even the Fed thought so.
How DJIA Earnings Could Make or Break This Rally
With the Dow Jones Industrial Average hitting new all-time highs this past week, we have to wonder what we have in store going forward as earnings reporting ramps up.
How Yum! Earnings Are Dominated by the Coming China Split
Yum! Brands, Inc. (NYSE: YUM) reported its most recent financial results after the markets closed on Wednesday. This fast food giant is taking a bite out of earnings in terms of China, but challenging…
Can Citigroup Book Value Outshine JPMorgan and Wells Fargo Earnings?
24/7 Wall St. wanted to see which big banks reporting earnings this week and next could make the biggest headway against their book values.
Why the Teva Acquisition Proves It Is a Stock to Own for the Decade
Even though the trend toward generic drugs is only likely to grow, the drug price pressures hanging over the sector also hurt most generic drug makers.
Cybersecurity Short Interest Backs Off
The June 30 short interest data have been compared with the previous figures, and short interest moves for most of the selected cybersecurity stocks were downward.
Short Interest in Social Media Remains Largely Down
The June 30 short interest data have been compared with the previous report. Short interest was down in most of these selected social media stocks.
Short Sellers Run for Cover From Major Pharma
The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest decreased.
Short Sellers Run for Cover From Major Semiconductors
The June 30 short interest data have been compared with the previous report. Short interest largely decreased in these selected semiconductor stocks.
Major Oil Short Interest Surges With the Markets
The June 30 short interest data have been compared with the previous figures, and short interest for most of the selected oil stocks increased.
Short Sellers Become More Selective on Major Biotechs
The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in these selected biotech stocks.
What to Expect From Yum Brands Earnings
Yum Brands is scheduled to release its second-quarter financial results after the markets close on Wednesday.
SEC Settles Blue Sheet Charges With Citigroup
The SEC has announced that Citigroup Global Markets has agreed to pay a $7 million penalty and admit wrongdoing to settle charges.
CytRx Crumbles on Late-Stage Whiff
CytRx absolutely crumbled in Tuesday’s session after the company released less than favorable late-stage results.
Valvoline Gears Up for IPO in Most Recent Filing
Valvoline has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Shire Gains Key FDA Approval in Dry Eye Treatment
Shire made waves Tuesday morning following a key FDA approval of its eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
Protagonist Therapeutics Files for IPO
Protagonist Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Biotechs With Drug Pipelines Closest to Zero Valuation
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
Sage Therapeutics Scores Huge Win in Depression Trial
Sage Therapeutics blew out expectations early on Tuesday morning after the company released results from its mid-stage depression trial.